These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9357411)

  • 21. Efficiency of ultrasound and biochemical markers for Down's syndrome risk screening. A prospective study.
    Benattar C; Audibert F; Taieb J; Ville Y; Roberto A; Lindenbaum A; Frydman R
    Fetal Diagn Ther; 1999; 14(2):112-7. PubMed ID: 10085510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
    Spencer K; Coombes EJ; Mallard AS; Ward AM
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():506-18. PubMed ID: 1280026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
    Milunsky A; Nebiolo LM; Bellet D
    Fetal Diagn Ther; 1993; 8(4):221-4. PubMed ID: 7505085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age.
    Cavalli P; Gnocchi E; Pennacchio A; Morrica B
    Prenat Diagn; 1998 Jun; 18(6):637-8. PubMed ID: 9664616
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
    Kadir RA; Economides DL
    Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing outcomes and costs between contingent and combined first-trimester screening strategies for Down's syndrome.
    Martín I; Gibert MJ; Aulesa C; Alsina M; Casals E; Bauça JM
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():13-8. PubMed ID: 25827079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum free beta-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome.
    Räty R; Virtanen A; Koskinen P; Anttila L; Forsström J; Laitinen P; Mörsky P; Tiitinen A; Ekblad U
    Hum Reprod; 2002 Feb; 17(2):481-4. PubMed ID: 11821299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of Down syndrome screening by maternal serum detection in mid-pregnancy].
    Liu YH; Li LF; Wu YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):532-4, 537. PubMed ID: 20335129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
    Wald NJ; Kennard A; Densem JW; Cuckle HS; Chard T; Butler L
    BMJ; 1992 Aug; 305(6850):391-4. PubMed ID: 1382768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study on population-based prenatal screening and diagnosis of Down's syndrome in Jiangsu province].
    Liu QL; Hu YL; Xu ZF; Wang LJ; Sun Q; Lin N; Xu XY; Liu Y; Zhang JW; Tong JS; Wang XH; He J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):340-2. PubMed ID: 20533279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gestational dating and Down's syndrome screening.
    Palomaki GE; Haddow JE
    Ann Clin Biochem; 1996 Jul; 33 ( Pt 4)():359-61. PubMed ID: 8836400
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved antenatal screening for Down's syndrome.
    Benn P
    Lancet; 2003 Mar; 361(9360):794-5. PubMed ID: 12642040
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down's syndrome screening: value of using free beta-hCG.
    Densem J; Wald NJ
    Prenat Diagn; 1995 Jan; 15(1):94-5. PubMed ID: 7537881
    [No Abstract]   [Full Text] [Related]  

  • 39. Prospective prenatal serum screening for Down syndrome in Venezuela.
    Alvarez-Nava F; Soto M; Morales-Machín A; Rojas A; Urdaneta K; Cañizález J
    Int J Gynaecol Obstet; 2008 Dec; 103(3):241-5. PubMed ID: 18817910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.